False
July 23, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
July 21, 2026
We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality
2 min read
July 20, 2026
First-in-human diabetes cell replacement, early iPSC-derived CAR T data in systemic sclerosis, AAV gene therapy for fragile X syndrome, and fresh funding for off-the-shelf CAR T
4 min read
July 20, 2026
IBTV speaks with industry leaders at Meeting on the Med 2026 to explore how automation, digitization, and new manufacturing models could make cell and gene therapy production more reproducible, efficient, and accessible
1 min read
July 17, 2026
Experts discuss the capabilities companies need to make drug development faster, more flexible, and more resilient – from integrated development and manufacturing flexibility to digital tools, supply chain strategy, and sharper decision-making
13 min read
July 15, 2026
Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next
8 min read
July 15, 2026
In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market
10 min read
July 14, 2026
Researchers retrofit a lab-scale monoclonal antibody purification platform with automation, OPC-UA connectivity, and model-based flow control
3 min read
July 14, 2026
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies
3 min read
False